Related Experiment Video
Updated: May 31, 2026

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
Published on: August 14, 2019
Influenza update 2000
1Section on Infectious Diseases, Department of Internal Medicine, Ochsner Clinic and Alton Ochsner Medical Foundation, New Orleans, LA.
Abstract:
Between 30,000-40,000 Americans die annually as a result of influenza epidemics. Spread primarily through the respiratory tract, influenza's classic signs and symptoms are the abrupt onset of fever, myalgia, headache, sore throat, malaise, and nonproductive cough. The elderly and patients with underlying medical illnesses may be at risk for secondary complications. Influenza is caused by an RNA myxovirus that exists in types A, B, and C; however, the A and B types are responsible for most human illness. The Centers for Disease Control and Prevention tracks the viruses' regular pathway through the US each year as they emerge first in Alaska and spread through the lower 48 states, peaking in activity during the winter months. Influenza is preventable by vaccination (efficacy 70%, depending on individual immune status) and is recommended for everyone at increased risk of complications from influenza between 6 months and 50 years of age, and universally for those over the age of 50. The composition of the vaccine has been changed for 2000-2001 to include two new type-A strains and one new type-B. Currently four drugs are available for the treatment of influenza. Early diagnosis can help reduce the inappropriate use of antibiotics and provide the option of using antiviral therapy. Bacterial infections can have similar symptoms or be complications of influenza and should be suspected and treated appropriately if present.
Related Concept Videos
Influenza
Vaccinations
Inhibitors Of Virion Release
Respiratory Syncytial Virus Disease
Arboviral Encephalitis
Infectious Diseases and Their Occurrence

